secondary malignancies

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

secondary malignancies

Dec 12, 2024, 16:30 | Insight

Miguel Bronchud about long term toxicities of CAR-T

Miguel Bronchud, Co-Founder and Advisory Board at Regenerative Medicine Solutions, shared a post on LinkedIn:…

Oct 13, 2024, 22:29 | Insight

Aaron Goodman: Hydroxyurea for Sickle Cell Anemia

Aaron Goodman shared a post on X: “Hydroxyurea for Sickle Cell Anemia! Good stuff! Mechanism…

Jul 9, 2024, 06:46 | Blog

David Cordas dos Santos: Nonrelapse mortality after CAR-T cell treatment

David Cordas dos Santos, PostDoc at Dana-Farber Cancer Institute, made the following post on X:…

Jul 8, 2024, 17:31 | Insight

Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality

Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…

Jun 17, 2024, 16:14 | Blog

Lorenz Mayr: The benefits of CAR-T therapy largely outweigh the potential risks of the CAR-T technology

Lorenz Mayr, CEO at Mayr BioMedTech Consulting, shared on LinkedIn: "Secondary Cancer Risk Is Low…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023